131 related articles for article (PubMed ID: 20629151)
1. Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.
Berg D; Seppi K; Liepelt I; Schweitzer K; Wollenweber F; Wolf B; Dillmann U; Stockner H; Godau J; Kiechl S; Gaenslen A; Willeit J; Di Santo A; Maetzler W; Gasser T; Poewe W; Behnke S
Mov Disord; 2010 Jul; 25(10):1464-9. PubMed ID: 20629151
[TBL] [Abstract][Full Text] [Related]
2. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
Liepelt I; Behnke S; Schweitzer K; Wolf B; Godau J; Wollenweber F; Dillmann U; Gaenslen A; Di Santo A; Maetzler W; Berg D
Neurobiol Aging; 2011 Sep; 32(9):1599-606. PubMed ID: 19897277
[TBL] [Abstract][Full Text] [Related]
3. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
López Hernández N; García Escrivá A; Shalabi Benavent M
Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
[TBL] [Abstract][Full Text] [Related]
5. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
[TBL] [Abstract][Full Text] [Related]
6. A population-based study on combined markers for early Parkinson's disease.
Tunc S; Graf J; Tadic V; Brüggemann N; Schmidt A; Al-Khaled M; Wolff S; Vollstedt EJ; Lorwin A; Hampf J; Piskol L; Klein C; Hagenah J; Kasten M
Mov Disord; 2015 Apr; 30(4):531-7. PubMed ID: 25546094
[TBL] [Abstract][Full Text] [Related]
7. Predictors for mild parkinsonian signs: a prospective population-based study.
Mahlknecht P; Kiechl S; Stockner H; Willeit J; Gasperi A; Poewe W; Seppi K
Parkinsonism Relat Disord; 2015 Mar; 21(3):321-4. PubMed ID: 25585991
[TBL] [Abstract][Full Text] [Related]
8. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
[TBL] [Abstract][Full Text] [Related]
9. Hyperechogenicity of the substantia nigra in Parkinson's disease.
Ressner P; Skoloudík D; Hlustík P; Kanovský P
J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
[TBL] [Abstract][Full Text] [Related]
10. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
[TBL] [Abstract][Full Text] [Related]
11. Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population.
Liepelt I; Wendt A; Schweitzer KJ; Wolf B; Godau J; Gaenslen A; Bruessel T; Berg D
J Neural Transm (Vienna); 2008 Jul; 115(7):993-9. PubMed ID: 18368284
[TBL] [Abstract][Full Text] [Related]
12. Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults.
Yilmaz R; Behnke S; Liepelt-Scarfone I; Roeben B; Pausch C; Runkel A; Heinzel S; Niebler R; Suenkel U; Eschweiler GW; Maetzler W; Berg D
Eur J Neurol; 2016 May; 23(5):973-8. PubMed ID: 26915334
[TBL] [Abstract][Full Text] [Related]
13. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.
Berg D; Seppi K; Behnke S; Liepelt I; Schweitzer K; Stockner H; Wollenweber F; Gaenslen A; Mahlknecht P; Spiegel J; Godau J; Huber H; Srulijes K; Kiechl S; Bentele M; Gasperi A; Schubert T; Hiry T; Probst M; Schneider V; Klenk J; Sawires M; Willeit J; Maetzler W; Fassbender K; Gasser T; Poewe W
Arch Neurol; 2011 Jul; 68(7):932-7. PubMed ID: 21747034
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
15. Relationship of substantia nigra echogenicity and motor function in elderly subjects.
Berg D; Siefker C; Ruprecht-Dörfler P; Becker G
Neurology; 2001 Jan; 56(1):13-7. PubMed ID: 11148229
[TBL] [Abstract][Full Text] [Related]
16. Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.
Berg D; Behnke S; Seppi K; Godau J; Lerche S; Mahlknecht P; Liepelt-Scarfone I; Pausch C; Schneider N; Gaenslen A; Brockmann K; Srulijes K; Huber H; Wurster I; Stockner H; Kiechl S; Willeit J; Gasperi A; Fassbender K; Gasser T; Poewe W
Mov Disord; 2013 Feb; 28(2):216-9. PubMed ID: 23115051
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra echomorphology and motor cortex excitability.
Todd G; Taylor JL; Baumann D; Butler JE; Duma SR; Hayes M; Carew-Jones F; Piguet O; Behnke S; Ridding MC; Berg D; Double KL
Neuroimage; 2010 May; 50(4):1351-6. PubMed ID: 20117219
[TBL] [Abstract][Full Text] [Related]
18. Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease.
Fan Y; Ma J; Yang D; Li X; Liang K; She Z; Qi X; Shi X; Gu Q; Zheng J; Li D
Eur J Neurosci; 2024 May; 59(10):2702-2714. PubMed ID: 38469656
[TBL] [Abstract][Full Text] [Related]
19. Relationship of substantia nigra hyperechogenicity to risk of Lewy body disease in idiopathic REM sleep behavior disorder patients: a longitudinal study.
Miyamoto M; Miyamoto T
Sleep Med; 2020 Apr; 68():31-34. PubMed ID: 32018190
[TBL] [Abstract][Full Text] [Related]
20. Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.
Kajimoto Y; Miwa H; Okawa-Izawa M; Hironishi M; Kondo T
Parkinsonism Relat Disord; 2009 May; 15(4):270-2. PubMed ID: 18691928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
